Changing Nature of High Risk Patients Undergoing Radical Prostatectomy-Reference-Cited by-同舟云学术

Changing Nature of High Risk Patients Undergoing Radical Prostatectomy

Published:2007-01 Issue:1 Volume:177 Page:113-117
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kane Christopher J.¹²,Presti Joseph C.³,Amling Christopher L.⁴,Aronson William J.⁵,Terris Martha K.⁶,Freedland Stephen J.⁷,

Affiliation:

1. Urology Section, Department of Surgery, Veterans Administration Medical Center San Francisco, San Francisco

2. Department of Urology, University of California, San Francisco School of Medicine, San Francisco

3. Department of Urology, Stanford University School of Medicine and Urology Section, Department of Surgery, Veterans Administration Medical Center Palo Alto, Palo Alto

4. Department of Urology, San Diego Naval Hospital, San Diego

5. Urology Section, Department of Surgery, Veterans Administration Greater Los Angeles Healthcare System and Department of Urology, University of California, Los Angeles School of Medicine, Los Angeles, California

6. Department of Surgery, Veterans Administration Medical Center Augusta and Section of Urology, Medical College of Georgia, Augusta, Georgia

7. Department of Surgery, Veterans Administration Medical Center Durham and Division of Urologic Surgery, Departments of Surgery and Pathology and Duke Prostate Center, Duke University School of Medicine, Durham, North Carolina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE);Cooperberg;J Urol,2003

2. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;JAMA,1998

3. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE);Meng;J Urol,2005

4. Role of radical retropubic prostatectomy in patients with locally advanced prostate cancer: the influence of Gleason score 8-10;Sciarra;Urol Int,2003

5. High-risk localized prostate cancer: primary surgery and adjuvant therapy;Skinner;Urol Oncol,2003

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer;European Urology;2022-09

2. Role of Androgen Receptor-Targeted Agents in Localized Prostate Cancer;Acta Clinica Croatica;2022

3. Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer;European Urology;2021-09

4. Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single-Dose Administration Under Fasting Conditions in Prostate Cancer;The Oncologist;2021-08-14

5. Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients;Frontiers in Oncology;2019-11-22